DALLAS--(BUSINESS WIRE)--Colossal Biosciences, the world’s first de-extinction company, has today announced an oversubscribed $150M Series B financing led by United States Innovative Technology Fund ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback